80 results on '"Garcia BL"'
Search Results
2. Contracubierta
- Author
-
García Blanco, Clara I., Alcocer Tocora, Milena, Álvarez-Suescún, Inéride, Amado Mateus, Marelby, and Cuero Acosta, Yonni A.
- Published
- 2022
3. Capítulo 16. El análisis de caso como estrategia de aprendizaje en los proyectos de tipo aprendizaje internacional colaborativo en línea (COIL): caso Universidad Autónoma de Guadalajara-Universidad del Rosario
- Author
-
García Blanco, Clara I., Alcocer Tocora, Milena, Álvarez-Suescún, Inéride, Amado Mateus, Marelby, and Cuero Acosta, Yonni A.
- Published
- 2022
4. Capítulo 12. Los MOOC, una herramienta de apoyo a las clases en acceso remoto
- Author
-
García Blanco, Clara I., Alcocer Tocora, Milena, Álvarez-Suescún, Inéride, Amado Mateus, Marelby, and Cuero Acosta, Yonni A.
- Published
- 2022
5. Reflexiones y consideraciones finales sobre las experiencias presentadas
- Author
-
García Blanco, Clara I., Alcocer Tocora, Milena, Álvarez-Suescún, Inéride, Amado Mateus, Marelby, and Cuero Acosta, Yonni A.
- Published
- 2022
6. Tercera Parte: Aprendizaje Experiencial en Espacios de Colaboración Internacional
- Author
-
García Blanco, Clara I., Alcocer Tocora, Milena, Álvarez-Suescún, Inéride, Amado Mateus, Marelby, and Cuero Acosta, Yonni A.
- Published
- 2022
7. Capítulo 15. COIL UR: un abecé para la internacionalización curricular de las aulas de administración y negocios
- Author
-
García Blanco, Clara I., Alcocer Tocora, Milena, Álvarez-Suescún, Inéride, Amado Mateus, Marelby, and Cuero Acosta, Yonni A.
- Published
- 2022
8. Capítulo 10. Gamificación: alternativa didáctica orientada a favorecer el aprendizaje de herramientas para la inclusión laboral de personas en desventaja social
- Author
-
García Blanco, Clara I., Alcocer Tocora, Milena, Álvarez-Suescún, Inéride, Amado Mateus, Marelby, and Cuero Acosta, Yonni A.
- Published
- 2022
9. Capítulo 14. Una aproximación educativa centrada en los estudiantes: el aprendizaje basado en retos como modelo para la formación posgradual en administración
- Author
-
García Blanco, Clara I., Alcocer Tocora, Milena, Álvarez-Suescún, Inéride, Amado Mateus, Marelby, and Cuero Acosta, Yonni A.
- Published
- 2022
10. Capítulo 13. Aprendizaje activo utilizando un enfoque desde lo humano. Área de Negocios Internacionales
- Author
-
García Blanco, Clara I., Alcocer Tocora, Milena, Álvarez-Suescún, Inéride, Amado Mateus, Marelby, and Cuero Acosta, Yonni A.
- Published
- 2022
11. Autores
- Author
-
García Blanco, Clara I., Alcocer Tocora, Milena, Álvarez-Suescún, Inéride, Amado Mateus, Marelby, and Cuero Acosta, Yonni A.
- Published
- 2022
12. Capítulo 11. Aprendizaje experiencial en programas de formación en investigación de la Escuela de Administración, Universidad del Rosario
- Author
-
García Blanco, Clara I., Alcocer Tocora, Milena, Álvarez-Suescún, Inéride, Amado Mateus, Marelby, and Cuero Acosta, Yonni A.
- Published
- 2022
13. Media página de título, Resumen, Página de título, Derechos de autor
- Author
-
García Blanco, Clara I., Alcocer Tocora, Milena, Álvarez-Suescún, Inéride, Amado Mateus, Marelby, and Cuero Acosta, Yonni A.
- Published
- 2022
14. Capítulo 3. Experiential learning in IB education through collaborative and multicultural strategies based on entrepreneurial challenges: X-Culture case
- Author
-
García Blanco, Clara I., Alcocer Tocora, Milena, Álvarez-Suescún, Inéride, Amado Mateus, Marelby, and Cuero Acosta, Yonni A.
- Published
- 2022
15. Capítulo 9. El análisis del entorno organizacional visto a través del juego (PEST-Quarto®)
- Author
-
García Blanco, Clara I., Alcocer Tocora, Milena, Álvarez-Suescún, Inéride, Amado Mateus, Marelby, and Cuero Acosta, Yonni A.
- Published
- 2022
16. Primera Parte: Conceptos y Lineamientos Generales Sobre el Aprendizaje Experiencial
- Author
-
García Blanco, Clara I., Alcocer Tocora, Milena, Álvarez-Suescún, Inéride, Amado Mateus, Marelby, and Cuero Acosta, Yonni A.
- Published
- 2022
17. Capítulo 1. El aprendizaje experiencial como modelo pedagógico en el campo de la administración
- Author
-
García Blanco, Clara I., Alcocer Tocora, Milena, Álvarez-Suescún, Inéride, Amado Mateus, Marelby, and Cuero Acosta, Yonni A.
- Published
- 2022
18. Segunda Parte: Experiencias de implementación en Escuelas de Administración y Negocios
- Author
-
García Blanco, Clara I., Alcocer Tocora, Milena, Álvarez-Suescún, Inéride, Amado Mateus, Marelby, and Cuero Acosta, Yonni A.
- Published
- 2022
19. Capítulo 2. El aprendizaje en laboratorios: el modelo UR STEAM
- Author
-
García Blanco, Clara I., Alcocer Tocora, Milena, Álvarez-Suescún, Inéride, Amado Mateus, Marelby, and Cuero Acosta, Yonni A.
- Published
- 2022
20. Introducción
- Author
-
García Blanco, Clara I., Alcocer Tocora, Milena, Álvarez-Suescún, Inéride, Amado Mateus, Marelby, and Cuero Acosta, Yonni A.
- Published
- 2022
21. Capítulo 6. Uso del laboratorio financiero para retos académicos internacionales. Casos ESG Research Challenge y Hemispheric Investment Challenge
- Author
-
García Blanco, Clara I., Alcocer Tocora, Milena, Álvarez-Suescún, Inéride, Amado Mateus, Marelby, and Cuero Acosta, Yonni A.
- Published
- 2022
22. Capítulo 5. Experiencia de estudio de casos y aprendizaje basado en proyectos desde un programa de magíster en administración y dirección de empresas chileno
- Author
-
García Blanco, Clara I., Alcocer Tocora, Milena, Álvarez-Suescún, Inéride, Amado Mateus, Marelby, and Cuero Acosta, Yonni A.
- Published
- 2022
23. Capítulo 4. Brick Building: realidad virtual y competencias emprendedoras en un contexto financiero
- Author
-
García Blanco, Clara I., Alcocer Tocora, Milena, Álvarez-Suescún, Inéride, Amado Mateus, Marelby, and Cuero Acosta, Yonni A.
- Published
- 2022
24. Capítulo 8. Aprender en contexto: Programa de Mentoring en las prácticas profesionales de la Escuela de Administración de la Universidad del Rosario
- Author
-
García Blanco, Clara I., Alcocer Tocora, Milena, Álvarez-Suescún, Inéride, Amado Mateus, Marelby, and Cuero Acosta, Yonni A.
- Published
- 2022
25. Capítulo 7. Social media in learning: estrategia educativa para transformar el aprendizaje en la era de la inflexión digital
- Author
-
García Blanco, Clara I., Alcocer Tocora, Milena, Álvarez-Suescún, Inéride, Amado Mateus, Marelby, and Cuero Acosta, Yonni A.
- Published
- 2022
26. The White Indians of Mexican Cinema
- Author
-
Garcia Blizzard, Mónica
- Subjects
Mexico ,cinema ,golden age - Abstract
The White Indians of Mexican Cinema theorizes the development of a unique form of racial masquerade—the representation of Whiteness as Indigeneity—during the Golden Age of Mexican cinema, from the 1930s to the 1950s. Adopting a broad decolonial perspective while remaining grounded in the history of local racial categories, Mónica García Blizzard argues that this trope works to reconcile two divergent discourses about race in postrevolutionary Mexico: the government-sponsored celebration of Indigeneity and mestizaje (or the process of interracial and intercultural mixing), on the one hand, and the idealization of Whiteness, on the other. Close readings of twenty films and primary source material illustrate how Mexican cinema has mediated race, especially in relation to gender, in ways that project national specificity, but also reproduce racist tendencies with respect to beauty, desire, and protagonism that survive to this day. This sweeping survey illuminates how Golden Age films produced diverse, even contradictory messages about the place of Indigeneity in the national culture.This book is freely available in an open access edition thanks to TOME (Toward an Open Monograph Ecosystem)—a collaboration of the Association of American Universities, the Association of University Presses, and the Association of Research Libraries—and the generous support of Emory University and the Andrew W. Mellon Foundation. Learn more at the TOME website, available at: https://www.openmonographs.org/. It can also be found in the SUNY Open Access Repository at: http://hdl.handle.net/20.500.12648/7153
- Published
- 2022
- Full Text
- View/download PDF
27. The Crystal Structure of the Michaelis-Menten Complex of C1 Esterase Inhibitor and C1s Reveals Novel Insights into Complement Regulation.
- Author
-
Garrigues RJ, Garrison MP, and Garcia BL
- Subjects
- Humans, Crystallography, X-Ray, Catalytic Domain, Protein Binding, Models, Molecular, Protein Conformation, Complement C1 Inhibitor Protein metabolism, Complement C1s metabolism, Complement C1s chemistry
- Abstract
The ancient arm of innate immunity known as the complement system is a blood proteolytic cascade involving dozens of membrane-bound and solution-phase components. Although many of these components serve as regulatory molecules to facilitate controlled activation of the cascade, C1 esterase inhibitor (C1-INH) is the sole canonical complement regulator belonging to a superfamily of covalent inhibitors known as serine protease inhibitors (SERPINs). In addition to its namesake role in complement regulation, C1-INH also regulates proteases of the coagulation, fibrinolysis, and contact pathways. Despite this, the structural basis for C1-INH recognition of its target proteases has remained elusive. In this study, we present the crystal structure of the Michaelis-Menten (M-M) complex of the catalytic domain of complement component C1s and the SERPIN domain of C1-INH at a limiting resolution of 3.94 Å. Analysis of the structure revealed that nearly half of the protein/protein interface is formed by residues outside of the C1-INH reactive center loop. The contribution of these residues to the affinity of the M-M complex was validated by site-directed mutagenesis using surface plasmon resonance. Parallel analysis confirmed that C1-INH-interfacing residues on C1s surface loops distal from the active site also drive affinity of the M-M complex. Detailed structural comparisons revealed differences in substrate recognition by C1s compared with C1-INH recognition and highlight the importance of exosite interactions across broader SERPIN/protease systems. Collectively, this study improves our understanding of how C1-INH regulates the classical pathway of complement, and it sheds new light on how SERPINs recognize their cognate protease targets., (Copyright © 2024 by The American Association of Immunologists, Inc.)
- Published
- 2024
- Full Text
- View/download PDF
28. New functions of pirin proteins and a 2-ketoglutarate: Ferredoxin oxidoreductase ortholog in Bacteroides fragilis metabolism and their impact on antimicrobial susceptibility to metronidazole and amixicile.
- Author
-
Gough AM, Parker AC, O'Bryan PJ, Whitehead TR, Roy S, Garcia BL, Hoffman PS, Jeffrey Smith C, and Rocha ER
- Subjects
- Bacterial Proteins genetics, Bacterial Proteins metabolism, Microbial Sensitivity Tests, Gene Expression Regulation, Bacterial, Bacteroides fragilis genetics, Bacteroides fragilis drug effects, Bacteroides fragilis enzymology, Bacteroides fragilis metabolism, Metronidazole pharmacology, Metronidazole metabolism, Anti-Bacterial Agents pharmacology, Anti-Bacterial Agents metabolism
- Abstract
The understanding of how central metabolism and fermentation pathways regulate antimicrobial susceptibility in the anaerobic pathogen Bacteroides fragilis is still incomplete. Our study reveals that B. fragilis encodes two iron-dependent, redox-sensitive regulatory pirin protein genes, pir1 and pir2. The mRNA expression of these genes increases when exposed to oxygen and during growth in iron-limiting conditions. These proteins, Pir1 and Pir2, influence the production of short-chain fatty acids and modify the susceptibility to metronidazole and amixicile, a new inhibitor of pyruvate: ferredoxin oxidoreductase in anaerobes. We have demonstrated that Pir1 and Pir2 interact directly with this oxidoreductase, as confirmed by two-hybrid system assays. Furthermore, structural analysis using AlphaFold2 predicts that Pir1 and Pir2 interact stably with several central metabolism enzymes, including the 2-ketoglutarate:ferredoxin oxidoreductases Kor1AB and Kor2CDAEBG. We used a series of metabolic mutants and electron transport chain inhibitors to demonstrate the extensive impact of bacterial metabolism on metronidazole and amixicile susceptibility. We also show that amixicile is an effective antimicrobial against B. fragilis in an experimental model of intra-abdominal infection. Our investigation led to the discovery that the kor2AEBG genes are essential for growth and have dual functions, including the formation of 2-ketoglutarate via the reverse TCA cycle. However, the metabolic activity that bypasses the function of Kor2AEBG following the addition of phospholipids or fatty acids remains undefined. Overall, our study provides new insights into the central metabolism of B. fragilis and its regulation by pirin proteins, which could be exploited for the development of new narrow-spectrum antimicrobials in the future., (© 2024 The Author(s). MicrobiologyOpen published by John Wiley & Sons Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
29. Current Trends in Artificial Intelligence and Bovine Mastitis Research: A Bibliometric Review Approach.
- Author
-
Mitsunaga TM, Nery Garcia BL, Pereira LBR, Costa YCB, da Silva RF, Delbem ACB, and Dos Santos MV
- Abstract
Mastitis, an important disease in dairy cows, causes significant losses in herd profitability. Accurate diagnosis is crucial for adequate control. Studies using artificial intelligence (AI) models to classify, identify, predict, and diagnose mastitis show promise in improving mastitis control. This bibliometric review aimed to evaluate AI and bovine mastitis terms in the most relevant Scopus-indexed papers from 2011 to 2021. Sixty-two documents were analyzed, revealing key terms, prominent researchers, relevant publications, main themes, and keyword clusters. "Mastitis" and "machine learning" were the most cited terms, with an increasing trend from 2018 to 2021. Other terms, such as "sensors" and "mastitis detection", also emerged. The United States was the most cited country and presented the largest collaboration network. Publications on mastitis and AI models notably increased from 2016 to 2021, indicating growing interest. However, few studies utilized AI for bovine mastitis detection, primarily employing artificial neural network models. This suggests a clear potential for further research in this area.
- Published
- 2024
- Full Text
- View/download PDF
30. The molecular determinants of classical pathway complement inhibition by OspEF-related proteins of Borrelia burgdorferi.
- Author
-
Thomas S, Schulz AM, Leong JM, Zeczycki TN, and Garcia BL
- Subjects
- Humans, Complement C1r metabolism, Complement C1r genetics, Complement C1s metabolism, Complement C1s genetics, Complement C1s chemistry, Lipoproteins metabolism, Lipoproteins genetics, Lipoproteins chemistry, Lipoproteins immunology, Lyme Disease genetics, Lyme Disease immunology, Lyme Disease microbiology, Protein Binding, Bacterial Outer Membrane Proteins chemistry, Bacterial Outer Membrane Proteins genetics, Bacterial Outer Membrane Proteins metabolism, Borrelia burgdorferi immunology, Borrelia burgdorferi metabolism, Borrelia burgdorferi genetics, Complement Pathway, Classical immunology
- Abstract
The complement system serves as the first line of defense against invading pathogens by promoting opsonophagocytosis and bacteriolysis. Antibody-dependent activation of complement occurs through the classical pathway and relies on the activity of initiating complement proteases of the C1 complex, C1r and C1s. The causative agent of Lyme disease, Borrelia burgdorferi, expresses two paralogous outer surface lipoproteins of the OspEF-related protein family, ElpB and ElpQ, that act as specific inhibitors of classical pathway activation. We have previously shown that ElpB and ElpQ bind directly to C1r and C1s with high affinity and specifically inhibit C2 and C4 cleavage by C1s. To further understand how these novel protease inhibitors function, we carried out a series of hydrogen-deuterium exchange mass spectrometry (HDX-MS) experiments using ElpQ and full-length activated C1s as a model of Elp-protease interaction. Comparison of HDX-MS profiles between unbound ElpQ and the ElpQ/C1s complex revealed a putative C1s-binding site on ElpQ. HDX-MS-guided, site-directed ElpQ mutants were generated and tested for direct binding to C1r and C1s using surface plasmon resonance. Several residues within the C-terminal region of ElpQ were identified as important for protease binding, including a single conserved tyrosine residue that was required for ElpQ- and ElpB-mediated complement inhibition. Collectively, our study identifies key molecular determinants for classical pathway protease recognition by Elp proteins. This investigation improves our understanding of the unique complement inhibitory mechanism employed by Elp proteins which serve as part of a sophisticated complement evasion system present in Lyme disease spirochetes., Competing Interests: Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article., (Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
31. Extended-Spectrum Beta-Lactamase-Producing Escherichia coli and Other Antimicrobial-Resistant Gram-Negative Pathogens Isolated from Bovine Mastitis: A One Health Perspective.
- Author
-
Nery Garcia BL, Dantas STA, da Silva Barbosa K, Mendes Mitsunaga T, Butters A, Camargo CH, and Nobrega DB
- Abstract
Antimicrobial resistance (AMR) poses an imminent threat to global public health, driven in part by the widespread use of antimicrobials in both humans and animals. Within the dairy cattle industry, Gram-negative coliforms such as Escherichia coli and Klebsiella pneumoniae stand out as major causative agents of clinical mastitis. These same bacterial species are frequently associated with severe infections in humans, including bloodstream and urinary tract infections, and contribute significantly to the alarming surge in antimicrobial-resistant bacterial infections worldwide. Additionally, mastitis-causing coliforms often carry AMR genes akin to those found in hospital-acquired strains, notably the extended-spectrum beta-lactamase genes. This raises concerns regarding the potential transmission of resistant bacteria and AMR from mastitis cases in dairy cattle to humans. In this narrative review, we explore the distinctive characteristics of antimicrobial-resistant E. coli and Klebsiella spp. strains implicated in clinical mastitis and human infections. We focus on the molecular mechanisms underlying AMR in these bacterial populations and critically evaluate the potential for interspecies transmission. Despite some degree of similarity observed in sequence types and mobile genetic elements between strains found in humans and cows, the existing literature does not provide conclusive evidence to assert that coliforms responsible for mastitis in cows pose a direct threat to human health. Finally, we also scrutinize the existing literature, identifying gaps and limitations, and propose avenues for future research to address these pressing challenges comprehensively.
- Published
- 2024
- Full Text
- View/download PDF
32. Inhibition of the C1s Protease and the Classical Complement Pathway by 6-(4-Phenylpiperazin-1-yl)Pyridine-3-Carboximidamide and Chemical Analogs.
- Author
-
Xu X, Herdendorf TJ, Duan H, Rohlik DL, Roy S, Zhou H, Alkhateeb H, Khandelwal S, Zhou Q, Li P, Arepally GM, Walker JK, Garcia BL, and Geisbrecht BV
- Subjects
- Animals, Sheep, Peptide Hydrolases, Complement C1 metabolism, Endopeptidases, Pyridines pharmacology, Complement Pathway, Classical, Complement C1s
- Abstract
The classical pathway (CP) is a potent mechanism for initiating complement activity and is a driver of pathology in many complement-mediated diseases. The CP is initiated via activation of complement component C1, which consists of the pattern recognition molecule C1q bound to a tetrameric assembly of proteases C1r and C1s. Enzymatically active C1s provides the catalytic basis for cleavage of the downstream CP components, C4 and C2, and is therefore an attractive target for therapeutic intervention in CP-driven diseases. Although an anti-C1s mAb has been Food and Drug Administration approved, identifying small-molecule C1s inhibitors remains a priority. In this study, we describe 6-(4-phenylpiperazin-1-yl)pyridine-3-carboximidamide (A1) as a selective, competitive inhibitor of C1s. A1 was identified through a virtual screen for small molecules that interact with the C1s substrate recognition site. Subsequent functional studies revealed that A1 dose-dependently inhibits CP activation by heparin-induced immune complexes, CP-driven lysis of Ab-sensitized sheep erythrocytes, CP activation in a pathway-specific ELISA, and cleavage of C2 by C1s. Biochemical experiments demonstrated that A1 binds directly to C1s with a Kd of ∼9.8 μM and competitively inhibits its activity with an inhibition constant (Ki) of ∼5.8 μM. A 1.8-Å-resolution crystal structure revealed the physical basis for C1s inhibition by A1 and provided information on the structure-activity relationship of the A1 scaffold, which was supported by evaluating a panel of A1 analogs. Taken together, our work identifies A1 as a new class of small-molecule C1s inhibitor and lays the foundation for development of increasingly potent and selective A1 analogs for both research and therapeutic purposes., (Copyright © 2024 by The American Association of Immunologists, Inc.)
- Published
- 2024
- Full Text
- View/download PDF
33. Digital health outreach to promote postpartum screening after gestational diabetes: A randomized factorial pilot study.
- Author
-
Brown SD, Garcia BL, Ritchie JL, Tsai AL, Millman A, Greenberg M, Quesenberry CP, and Ferrara A
- Abstract
Objective: We examined the acceptability and feasibility of a multi-component digital health outreach intervention to promote uptake of guideline-recommended postpartum screening for type 2 diabetes among patients with gestational diabetes (GDM)., Methods: We conducted a 2
4 randomized factorial experiment as part of the Multiphase Optimization Strategy (MOST) preparation phase for developing behavioral interventions. Participants with current or recent GDM in an integrated healthcare system were randomized to receive an outreach message with up to four intervention components, designed to be self-administered in about 10 min and efficiently delivered online via REDCap: a streamlined values affirmation, personalized information on diabetes risk, an interactive motivational interviewing-based component, and an interactive action planning component. Patient-reported acceptability and feasibility outcomes were assessed via survey., Results: Among 162 participants, 72% self-identified with a racial/ethnic minority group. Across components, acceptability scores averaged 3.9/5; ≥91% of participants read most or all of the outreach message; ≥89% perceived the amount of information as "about right"; and ≥ 87% completed ≥1 interactive prompt., Conclusion: Each intervention component was acceptable to diverse patients and feasible to deliver in a brief, self-directed, online format., Innovation: These novel components target unaddressed barriers to patient engagement in guideline-recommended postpartum diabetes screening and adapt theory-based behavior change techniques for large-scale use., Competing Interests: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Susan D. Brown reports financial support was provided by the Kaiser Permanente Northern California Division of Research and the 10.13039/100000062National Institute of Diabetes and Digestive and Kidney Diseases., (© 2024 The Authors.)- Published
- 2024
- Full Text
- View/download PDF
34. Investigating membrane-binding properties of lipoxygenases using surface plasmon resonance.
- Author
-
Rohlik DL, Patel E, Gilbert NC, Offenbacher AR, and Garcia BL
- Subjects
- Animals, Humans, Lipid Bilayers, Cell Membrane, Liposomes, Mammals, Lipoxygenases, Surface Plasmon Resonance
- Abstract
Lipoxygenases (LOXs) catalyze the oxidation of polyunsaturated fatty acids and synthesize oxylipin products that drive important cellular signaling processes in plants and animals. While there has been indirect evidence presented for the interaction of mammalian LOXs with membranes, a quantitative study of the molecular details of LOX-membrane interactions is lacking. Here, we mimicked biological membranes using surface plasmon resonance (SPR) sensor chips derivatized with 2-D planar lipophilic anchors (2D LP) to capture liposomes of varying phospholipid compositions that self-assemble into lipid bilayers on the SPR chip. The sensor chip surfaces were then used to investigate the membrane-binding properties of model LOX enzymes. SPR binding assays displayed reproducible and stable liposome capture to the sensor chip surface that allowed for the detailed characterization of LOX-membrane interactions. Our studies demonstrate a calcium-dependence for the membrane binding activities of coral 8R-LOX and human 15-LOX-2. Furthermore, our data confirm the importance of key membrane insertion loop residues in each of these LOX enzymes for membrane binding activity. Experiments utilizing model plant and human LOXs reveal differences in membrane-binding specificities. Our study establishes and validates a robust SPR-based platform using 2D LP sensor chips that allows for the detailed study of LOX-membrane interactions under different experimental conditions, including altered membrane compositions. Collectively, this investigation improves our overall understanding of LOX-membrane interaction properties, and our SPR-based approach holds potential for future use in the development of LOX-based therapeutics., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023 Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
35. Conformational dynamics of complement protease C1r inhibitor proteins from Lyme disease- and relapsing fever-causing spirochetes.
- Author
-
Roy S, Booth CE Jr, Powell-Pierce AD, Schulz AM, Skare JT, and Garcia BL
- Subjects
- Humans, Protein Domains, Crystallography, X-Ray, Bacterial Proteins chemistry, Lyme Disease immunology, Lyme Disease microbiology, Relapsing Fever immunology, Relapsing Fever microbiology, Complement C1 Inactivator Proteins chemistry, Borrelia
- Abstract
Borrelial pathogens are vector-borne etiological agents known to cause Lyme disease, relapsing fever, and Borrelia miyamotoi disease. These spirochetes each encode several surface-localized lipoproteins that bind components of the human complement system to evade host immunity. One borrelial lipoprotein, BBK32, protects the Lyme disease spirochete from complement-mediated attack via an alpha helical C-terminal domain that interacts directly with the initiating protease of the classical complement pathway, C1r. In addition, the B. miyamotoi BBK32 orthologs FbpA and FbpB also inhibit C1r, albeit via distinct recognition mechanisms. The C1r-inhibitory activities of a third ortholog termed FbpC, which is found exclusively in relapsing fever-causing spirochetes, remains unknown. Here, we report the crystal structure of the C-terminal domain of Borrelia hermsii FbpC to a limiting resolution of 1.5 Å. We used surface plasmon resonance and assays of complement function to demonstrate that FbpC retains potent BBK32-like anticomplement activities. Based on the structure of FbpC, we hypothesized that conformational dynamics of the complement inhibitory domains of borrelial C1r inhibitors may differ. To test this, we utilized the crystal structures of the C-terminal domains of BBK32, FbpA, FbpB, and FbpC to carry out molecular dynamics simulations, which revealed borrelial C1r inhibitors adopt energetically favored open and closed states defined by two functionally critical regions. Taken together, these results advance our understanding of how protein dynamics contribute to the function of bacterial immune evasion proteins and reveal a surprising plasticity in the structures of borrelial C1r inhibitors., Competing Interests: Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article., (Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
36. Atrial cardiopathy in young adults with embolic stroke of undetermined source: a myocardial deformation imaging analysis.
- Author
-
Pires CM, Silva R, Garcia BL, Antunes N, Vieira C, Marques J, Queirós S, and Pereira VH
- Subjects
- Humans, Young Adult, Adolescent, Adult, Middle Aged, Aged, Tomography, X-Ray Computed, Predictive Value of Tests, Risk Factors, Stroke diagnostic imaging, Stroke etiology, Atrial Fibrillation, Embolic Stroke complications, Heart Diseases complications, Heart Diseases diagnostic imaging, Intracranial Embolism epidemiology, Intracranial Embolism etiology
- Abstract
Background: Atrial cardiopathy (AC) has emerged as a potential pathological thrombogenic atrial substract of embolic stroke of undetermined source (ESUS), even in the absence of atrial fibrillation. Left atrium (LA) myocardial deformation analysis may be of value as a subclinical marker of AC and a predictor of ESUS., Aims: To compare LA mechanical function between ESUS cases and age and sex-matched controls., Methods: A single-center analytical study with case-control design was performed. Case group was composed by young patients admitted in the Neurology department from January 2017 to June 2021. Control group was composed by age and sex matched controls recruited from the community. All participants performed echocardiogram and a smaller sample underwent cardiac magnetic resonance., Results: We recruited 31 ESUS patients aged between 18 and 65 years and 31 age and sex matched controls. ESUS patients had a significantly higher prevalence of cardiovascular risk factors and patent foramen ovale (PFO). The prevalence of AC was not different between groups. Echocardiogram parameters, including strain analysis, were similar between groups, except for LA appendage (LAA) ostium variation which was significantly lower in ESUS patients (absolute: 6.5vs8.7mm, p<0.001; relative: 44.5%vs53.4%, p=0.002). After exclusion of patients with PFO, all the results were statistically similar. Regarding cardiac magnetic resonance analysis, there were no statistically significant differences between groups., Conclusion: This study shows that in our population atria cardiopathy and atrial function was not associated with ESUS.LAA structural and functional abnormalities may play a major role. The role of LAA in ESUS warrants further studies., (© 2022. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
37. "Conformational dynamics of C1r inhibitor proteins from Lyme disease and relapsing fever spirochetes".
- Author
-
Roy S, Booth CE Jr, Powell-Pierce AD, Schulz AM, Skare JT, and Garcia BL
- Abstract
Borrelial pathogens are vector-borne etiological agents of Lyme disease, relapsing fever, and Borrelia miyamotoi disease. These spirochetes each encode several surface-localized lipoproteins that bind to components of the human complement system. BBK32 is an example of a borrelial lipoprotein that protects the Lyme disease spirochete from complement-mediated attack. The complement inhibitory activity of BBK32 arises from an alpha helical C-terminal domain that interacts directly with the initiating protease of the classical pathway, C1r. Borrelia miyamotoi spirochetes encode BBK32 orthologs termed FbpA and FbpB, and these proteins also inhibit C1r, albeit via distinct recognition mechanisms. The C1r-inhibitory activities of a third ortholog termed FbpC, which is found exclusively in relapsing fever spirochetes, remains unknown. Here we report the crystal structure of the C-terminal domain of B. hermsii FbpC to a limiting resolution of 1.5 Å. Surface plasmon resonance studies and assays of complement function demonstrate that FbpC retains potent BBK32-like anti-complement activities. Based on the structure of FbpC, we hypothesized that conformational dynamics of the complement inhibitory domains of borrelial C1r inhibitors may differ. To test this, we utilized the crystal structures of the C-terminal domains of BBK32, FbpA, FbpB, and FbpC to carry out 1 µs molecular dynamics simulations, which revealed borrelial C1r inhibitors adopt energetically favored open and closed states defined by two functionally critical regions. This study advances our understanding of how protein dynamics contribute to the function of bacterial immune evasion proteins and reveals a surprising plasticity in the structures of borrelial C1r inhibitors.
- Published
- 2023
- Full Text
- View/download PDF
38. Soluble CD25 imposes a low-zone IL-2 signaling environment that favors competitive outgrowth of antigen-experienced CD25 high regulatory and memory T cells.
- Author
-
Nickle RA, DeOca KB, Garcia BL, and Mannie MD
- Subjects
- Humans, Mice, Animals, Memory T Cells, Interleukin-2 Receptor alpha Subunit metabolism, Forkhead Transcription Factors metabolism, T-Lymphocytes, Regulatory metabolism, Interleukin-2 metabolism
- Abstract
This study focused on soluble (s)CD25-mediated regulation of IL-2 signaling in murine and human CD4
+ T cells. Recombinant sCD25 reversibly sequestered IL-2 to limit acute maximal proliferative responses while preserving IL-2 bioavailability to subsequently maintain low-zone IL-2 signaling during prolonged culture. By inhibiting IL-2 signaling during acute activation, sCD25 suppressed T-cell growth and inhibited IL-2-evoked transmembrane CD25 expression, thereby resulting in lower prevalence of CD25high T cells. By inhibiting IL-2 signaling during quiescent IL-2-mediated growth, sCD25 competed with transmembrane CD25, IL2Rβγ, and IL2Rαβγ receptors for limited pools of IL-2 such that sCD25 exhibited strong or weak inhibitory efficacy in IL-2-stimulated cultures of CD25low or CD25high T cells, respectively. Preferential blocking of IL-2 signaling in CD25low but not CD25high T cells caused competitive enrichment of CD25high memory/effector and regulatory FOXP3+ subsets. In conclusion, sCD25 modulates IL-2 bioavailability to limit CD25 expression during acute activation while enhancing CD25high T-cell dominance during low-zone homeostatic IL-2-mediated expansion, thereby 'flattening' the inflammatory curve over time., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.)- Published
- 2023
- Full Text
- View/download PDF
39. Prehospital Stroke Triage: A Modeling Study on the Impact of Triage Tools in Different Regions.
- Author
-
Duvekot MHC, Garcia BL, Dekker L, Nguyen TM, van den Wijngaard IR, de Laat KF, de Schryver ELLM, Kloos LMH, Aerden LAM, Zylicz SA, Bosch J, van Belle E, van Zwet EW, Rozeman AD, Moudrous W, Vermeij FH, Lingsma HF, Bakker J, van Doormaal PJ, van Es ACGM, van der Lugt A, Wermer MJH, Dippel DWJ, Kerkhoff H, Roozenbeek B, Kruyt ND, and Venema E
- Subjects
- Humans, Triage, Prospective Studies, Fibrinolytic Agents therapeutic use, Thrombolytic Therapy, Treatment Outcome, Brain Ischemia diagnosis, Emergency Medical Services, Stroke therapy, Stroke drug therapy
- Abstract
Background and Purpose: Direct transportation to a thrombectomy-capable intervention center is beneficial for patients with ischemic stroke due to large vessel occlusion (LVO), but can delay intravenous thrombolytics (IVT). The aim of this modeling study was to estimate the effect of prehospital triage strategies on treatment delays and overtriage in different regions., Methods: We used data from two prospective cohort studies in the Netherlands: the Leiden Prehospital Stroke Study and the PRESTO study. We included stroke code patients within 6 h from symptom onset. We modeled outcomes of Rapid Arterial oCclusion Evaluation (RACE) scale triage and triage with a personalized decision tool, using drip-and-ship as reference. Main outcomes were overtriage (stroke code patients incorrectly triaged to an intervention center), reduced delay to endovascular thrombectomy (EVT), and delay to IVT., Results: We included 1798 stroke code patients from four ambulance regions. Per region, overtriage ranged from 1-13% (RACE triage) and 3-15% (personalized tool). Reduction of delay to EVT varied by region between 24 ± 5 min ( n = 6) to 78 ± 3 ( n = 2), while IVT delay increased with 5 ( n = 5) to 15 min ( n = 21) for non-LVO patients. The personalized tool reduced delay to EVT for more patients (25 ± 4 min [ n = 8] to 49 ± 13 [ n = 5]), while delaying IVT with 3-14 min (8-24 patients). In region C, most EVT patients were treated faster (reduction of delay to EVT 31 ± 6 min ( n = 35), with RACE triage and the personalized tool., Conclusions: In this modeling study, we showed that prehospital triage reduced time to EVT without disproportionate IVT delay, compared to a drip-and-ship strategy. The effect of triage strategies and the associated overtriage varied between regions. Implementation of prehospital triage should therefore be considered on a regional level.
- Published
- 2023
- Full Text
- View/download PDF
40. Outer surface lipoproteins from the Lyme disease spirochete exploit the molecular switch mechanism of the complement protease C1s.
- Author
-
Garrigues RJ, Thomas S, Leong JM, and Garcia BL
- Subjects
- Humans, Complement C1s chemistry, Complement C1s metabolism, Complement C4 chemistry, Complement System Proteins metabolism, Serine Proteases, Lipoproteins genetics, Borrelia burgdorferi genetics, Lyme Disease
- Abstract
Proteolytic cascades comprise several important physiological systems, including a primary arm of innate immunity called the complement cascade. To safeguard against complement-mediated attack, the etiologic agent of Lyme disease, Borreliella burgdorferi, produces numerous outer surface-localized lipoproteins that contribute to successful complement evasion. Recently, we discovered a pair of B. burgdorferi surface lipoproteins of the OspEF-related protein family-termed ElpB and ElpQ-that inhibit antibody-mediated complement activation. In this study, we investigate the molecular mechanism of ElpB and ElpQ complement inhibition using an array of biochemical and biophysical approaches. In vitro assays of complement activation show that an independently folded homologous C-terminal domain of each Elp protein maintains full complement inhibitory activity and selectively inhibits the classical pathway. Using binding assays and complement component C1s enzyme assays, we show that binding of Elp proteins to activated C1s blocks complement component C4 cleavage by competing with C1s-C4 binding without occluding the active site. C1s-mediated C4 cleavage is dependent on activation-induced binding sites, termed exosites. To test whether these exosites are involved in Elp-C1s binding, we performed site-directed mutagenesis, which showed that ElpB and ElpQ binding require C1s residues in the anion-binding exosite located on the serine protease domain of C1s. Based on these results, we propose a model whereby ElpB and ElpQ exploit activation-induced conformational changes that are normally important for C1s-mediated C4 cleavage. Our study expands the known complement evasion mechanisms of microbial pathogens and reveals a novel molecular mechanism for selective C1s inhibition by Lyme disease spirochetes., Competing Interests: Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article., (Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
41. Minimal role for the alternative pathway in complement activation by HIT immune complexes.
- Author
-
Barnes AP, Khandelwal S, Sartoretto S, Myoung S, Francis SJ, Lee GM, Rauova L, Cines DB, Skare JT, Booth CE Jr, Garcia BL, and Arepally GM
- Subjects
- Humans, Complement Factor D, Heparin adverse effects, Complement Activation, Complement System Proteins, Immunoglobulin G, Receptors, Complement, Esterases adverse effects, Antigen-Antibody Complex, Thrombocytopenia
- Abstract
Background: Anti-platelet factor 4 (PF4)/heparin immune complexes that cause heparin-induced thrombocytopenia (HIT) activate complement via the classical pathway. Previous studies have shown that the alternative pathway of complement substantially amplifies the classical pathway of complement activation through the C3b feedback cycle., Objectives: These studies sought to examine the contributions of the alternative pathway to complement activation by HIT antibodies., Methods: Using IgG monoclonal (KKO) and/or patient-derived HIT antibodies, we compared the effects of classical pathway (BBK32 and C1-esterase inhibitor [C1-INH]), alternative pathway (anti-factor B [fB] or factor D [fD] inhibitor) or combined classical and alternative pathway inhibition (soluble complement receptor 1 [sCR1]) in whole blood or plasma., Results: Classical pathway inhibitors BBK32 and C1-INH and the combined classical/alternative pathway inhibitor sCR1 prevented KKO/HIT immune complex-induced complement activation, including release of C3 and C5 activation products, binding of immune complexes to B cells, and neutrophil activation. The alternative pathway inhibitors fB and fD, however, did not affect complement activation by KKO/HIT immune complexes. Similarly, alternative pathway inhibition had no effect on complement activation by unrelated immune complexes consisting of anti-dinitrophenyl (DNP) antibody and the multivalent DNP--keyhole limpet hemocyanin antigen., Conclusions: Collectively, these findings suggest the alternative pathway contributes little in support of complement activation by HIT immune complexes. Additional in vitro and in vivo studies are required to examine if this property is shared by most IgG-containing immune complexes or if predominance of the classic pathway is limited to immune complexes composed of multivalent antigens., (© 2022 International Society on Thrombosis and Haemostasis.)
- Published
- 2022
- Full Text
- View/download PDF
42. BAFF antagonism via the BAFF receptor 3 binding site attenuates BAFF 60-mer-induced classical NF-κB signaling and metabolic reprogramming of B cells.
- Author
-
D Lempicki M, Paul S, Serbulea V, Upchurch CM, Sahu S, Gray JA, Ailawadi G, Garcia BL, McNamara CA, Leitinger N, and Meher AK
- Subjects
- Humans, B-Cell Activation Factor Receptor metabolism, Metabolic Reprogramming, Binding Sites, Glucose, NF-kappa B metabolism, B-Cell Activating Factor genetics
- Abstract
Human recombinant B cell activating factor (BAFF) is secreted as 3-mers, which can associate to form 60-mers in culture supernatants. However, the presence of BAFF multimers in humans is still debated and it is incompletely understood how BAFF multimers activate the B cells. Here, we demonstrate that BAFF can exist as 60-mers or higher order multimers in human plasma. In vitro, BAFF 60-mer strongly induced the transcriptome of B cells which was partly attenuated by antagonism using a soluble fragment of BAFF receptor 3. Furthermore, compared to BAFF 3-mer, BAFF 60-mer strongly induced a transient classical and prolonged alternate NF-κB signaling, glucose oxidation by both aerobic glycolysis and oxidative phosphorylation, and succinate utilization by mitochondria. BAFF antagonism selectively attenuated classical NF-κB signaling and glucose oxidation. Altogether, our results suggest critical roles of BAFF 60-mer and its BAFF receptor 3 binding site in hyperactivation of B cells., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Published by Elsevier Inc.)
- Published
- 2022
- Full Text
- View/download PDF
43. Comparison of antibacterial and antibiofilm activity of bioactive glass compounds S53P4 and 45S5.
- Author
-
Zhou P, Garcia BL, and Kotsakis GA
- Subjects
- Biocompatible Materials chemistry, Biocompatible Materials pharmacology, Biofilms, Humans, Pseudomonas aeruginosa, Anti-Bacterial Agents chemistry, Anti-Bacterial Agents pharmacology, Osteomyelitis microbiology
- Abstract
Background: Bone loss and deformation due to damage caused by injury or recurrent invasive infections presents a major clinical obstacle. While bone substitute biomaterials promote osseous tissue regeneration, their application in sites complicated by microbial infections such as osteomyelitis, is limited. Bioactive glass biomaterials (Bioglass) have been shown to have efficient mechanisms of repairing the integrity of bone, while inhibiting growth of a range of bacterial strains. There are several commercially available bioactive glass compounds, each with a unique chemical composition. One compound in particular, S53P4, has demonstrated antimicrobial effects in previous studies but the antimicrobial activity of the parent compound 45S5 has not been investigated., Results: To assess whether antimicrobial activity is common among bioglass compounds, 45S5-the parent compound, was evaluated in comparison to S53P4 for antibacterial and antibiofilm effects against multiple strains of aerobic and anaerobic bacteria associated with various types of osteomyelitis. Experiments of antimicrobial effects in liquid cultures demonstrated that both compounds were antimicrobial against various microbial genera including S. gordonii, V. parvula, P. aeruginosa and MRSA; particles of the smallest size (32-125 µm) invariably showed the most robust antimicrobial capabilities. When employed against biofilms ecological biofilms grown on hydroxyapatite, 45S5 particles produced a stronger reduction in biofilm mass compared to S53P4 particles when considering small particle ranges., Conclusion: We found that 45S5 seems to be as effective as S53P4 and possibly even more capable of limiting bacterial infections. The efficacy of bioactive glass was not limited to inhibition of planktonic growth, as it also extended to bacterial biofilms. The increased antibacterial activity of 45S5 compared to S53P4 is true for a variety of size ranges., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
44. gC1qR/C1qBP/HABP-1: Structural Analysis of the Trimeric Core Region, Interactions With a Novel Panel of Monoclonal Antibodies, and Their Influence on Binding to FXII.
- Author
-
Zhang Y, Vontz AJ, Kallenberger EM, Xu X, Ploscariu NT, Ramyar KX, Garcia BL, Ghebrehiwet B, and Geisbrecht BV
- Subjects
- Cell Membrane metabolism, Endothelial Cells metabolism, Kininogen, High-Molecular-Weight metabolism, Antibodies, Monoclonal, Factor XII genetics, Factor XII metabolism
- Abstract
The protein gC1qR/C1qBP/HABP-1 plays an essential role in mitochondrial biogenesis, but becomes localized at the cellular surface in numerous pathophysiological states. When this occurs on endothelial cells, surface-exposed gC1qR activates the classical pathway of complement. It also promotes assembly of a multi-protein complex comprised of coagulation factor XII (FXII), pre-kallikrein (PK), and high-molecular weight kininogen (HMWK) that activates the contact system and the kinin-generating system. Since surface-exposed gC1qR triggers intravascular inflammatory pathways, there is interest in identifying molecules that block gC1qR function. Here we further that objective by reporting the outcome of a structure/function investigation of gC1qR, its interactions with FXII, and the impact of a panel of monoclonal anti-gC1qR antibodies on FXII binding to gC1qR. Although deletion mutants have been used extensively to assess gC1qR function, none of these proteins have been characterized structurally. To that end, we determined a 2.2 Å resolution crystal structure of a gC1qR mutant lacking both of its acidic loops, but which retained nanomolar-affinity binding to FXII and FXIIa. This structure revealed that the trimeric gC1qR assembly was maintained despite loss of roughly thirty residues. Characterization of a novel panel of anti-gC1qR monoclonal antibodies identified several with biochemical properties distinct from previously described antibodies, as well as one which bound to the first acidic loop of gC1qR. Intriguingly, we found that each of these antibodies could partly inhibit binding of FXII and FXIIa to gC1qR. Based on these results and previously published studies, we offer new perspectives for developing gC1qR inhibitors., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Zhang, Vontz, Kallenberger, Xu, Ploscariu, Ramyar, Garcia, Ghebrehiwet and Geisbrecht.)
- Published
- 2022
- Full Text
- View/download PDF
45. Borrelia miyamotoi FbpA and FbpB Are Immunomodulatory Outer Surface Lipoproteins With Distinct Structures and Functions.
- Author
-
Booth CE Jr, Powell-Pierce AD, Skare JT, and Garcia BL
- Subjects
- Complement System Proteins metabolism, Fibronectins, Humans, Lipoproteins, Bacterial Proteins metabolism, Borrelia physiology, Borrelia burgdorferi, Lyme Disease
- Abstract
Pathogens that traffic in the blood of their hosts must employ mechanisms to evade the host innate immune system, including the complement cascade. The Lyme disease spirochete, Borreliella burgdorferi , has evolved numerous outer membrane lipoproteins that interact directly with host proteins. Compared to Lyme disease-associated spirochetes, relatively little is known about how an emerging tick-borne spirochetal pathogen, Borrelia miyamotoi , utilizes surface lipoproteins to interact with a human host. B. burgdorferi expresses the multifunctional lipoprotein, BBK32, that inhibits the classical pathway of complement through interaction with the initiating protease C1r, and also interacts with fibronectin using a separate intrinsically disordered domain. B. miyamotoi encodes two separate bbk32 orthologs denoted fbpA and fbpB ; however, the activities of these proteins are unknown. Here, we show that B. miyamotoi FbpA binds human fibronectin in a manner similar to B. burgdorferi BBK32, whereas FbpB does not. FbpA and FbpB both bind human complement C1r and protect a serum-sensitive B. burgdorferi strain from complement-mediated killing, but surprisingly, differ in their ability to recognize activated C1r versus zymogen states of C1r. To better understand the observed differences in C1r recognition and inhibition properties, high-resolution X-ray crystallography structures were solved of the C1r-binding regions of B. miyamotoi FbpA and FbpB at 1.9Å and 2.1Å, respectively. Collectively, these data suggest that FbpA and FbpB have partially overlapping functions but are functionally and structurally distinct. The data presented herein enhances our overall understanding of how bloodborne pathogens interact with fibronectin and modulate the complement system., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Booth, Powell-Pierce, Skare and Garcia.)
- Published
- 2022
- Full Text
- View/download PDF
46. Lipoproteome screening of the Lyme disease agent identifies inhibitors of antibody-mediated complement killing.
- Author
-
Pereira MJ, Wager B, Garrigues RJ, Gerlach E, Quinn JD, Dowdell AS, Osburne MS, Zückert WR, Kraiczy P, Garcia BL, and Leong JM
- Subjects
- Humans, Immunoglobulins immunology, Proteome immunology, Bacterial Proteins immunology, Borrelia burgdorferi immunology, Complement C1q immunology, Immune Evasion, Lipoproteins immunology, Lyme Disease immunology, Lyme Disease microbiology
- Abstract
Spirochetal pathogens, such as the causative agent of Lyme disease, Borrelia burgdorferi sensu lato, encode an abundance of lipoproteins; however, due in part to their evolutionary distance from more well-studied bacteria, such as Proteobacteria and Firmicutes, few spirochetal lipoproteins have assigned functions. Indeed, B. burgdorferi devotes almost 8% of its genome to lipoprotein genes and interacts with its environment primarily through the production of at least 80 surface-exposed lipoproteins throughout its tick vector–vertebrate host lifecycle. Several B. burgdorferi lipoproteins have been shown to serve roles in cellular adherence or immune evasion, but the functions for most B. burgdorferi surface lipoproteins remain unknown. In this study, we developed a B. burgdorferi lipoproteome screening platform utilizing intact spirochetes that enables the identification of previously unrecognized host interactions. As spirochetal survival in the bloodstream is essential for dissemination, we targeted our screen to C1, the first component of the classical (antibody-initiated) complement pathway. We identified two high-affinity C1 interactions by the paralogous lipoproteins, ElpB and ElpQ (also termed ErpB and ErpQ, respectively). Using biochemical, microbiological, and biophysical approaches, we demonstrate that ElpB and ElpQ bind the activated forms of the C1 proteases, C1r and C1s, and represent a distinct mechanistic class of C1 inhibitors that protect the spirochete from antibody-mediated complement killing. In addition to identifying a mode of complement inhibition, our study establishes a lipoproteome screening methodology as a discovery platform for identifying direct host–pathogen interactions that are central to the pathogenesis of spirochetes, such as the Lyme disease agent.
- Published
- 2022
- Full Text
- View/download PDF
47. A Structural Basis for Inhibition of the Complement Initiator Protease C1r by Lyme Disease Spirochetes.
- Author
-
Garrigues RJ, Powell-Pierce AD, Hammel M, Skare JT, and Garcia BL
- Subjects
- Bacterial Proteins chemistry, Borrelia burgdorferi immunology, Humans, Models, Molecular, Bacterial Proteins immunology, Borrelia burgdorferi chemistry, Complement C1r immunology, Lyme Disease immunology, Peptide Hydrolases immunology
- Abstract
Complement evasion is a hallmark of extracellular microbial pathogens such as Borrelia burgdorferi , the causative agent of Lyme disease. Lyme disease spirochetes express nearly a dozen outer surface lipoproteins that bind complement components and interfere with their native activities. Among these, BBK32 is unique in its selective inhibition of the classical pathway. BBK32 blocks activation of this pathway by selectively binding and inhibiting the C1r serine protease of the first component of complement, C1. To understand the structural basis for BBK32-mediated C1r inhibition, we performed crystallography and size-exclusion chromatography-coupled small angle X-ray scattering experiments, which revealed a molecular model of BBK32-C in complex with activated human C1r. Structure-guided site-directed mutagenesis was combined with surface plasmon resonance binding experiments and assays of complement function to validate the predicted molecular interface. Analysis of the structures shows that BBK32 inhibits activated forms of C1r by occluding substrate interaction subsites (i.e., S1 and S1') and reveals a surprising role for C1r B loop-interacting residues for full inhibitory activity of BBK32. The studies reported in this article provide for the first time (to our knowledge) a structural basis for classical pathway-specific inhibition by a human pathogen., (Copyright © 2021 by The American Association of Immunologists, Inc.)
- Published
- 2021
- Full Text
- View/download PDF
48. Optimal patient protocols in regional acute stroke care.
- Author
-
Garcia BL, Bekker R, van der Mei RD, Chavannes NH, and Kruyt ND
- Subjects
- Critical Care, Humans, Thrombolytic Therapy, Brain Ischemia drug therapy, Emergency Medical Services, Stroke therapy
- Abstract
In acute stroke care two proven reperfusion treatments exist: (1) a blood thinner and (2) an interventional procedure. The interventional procedure can only be given in a stroke centre with specialized facilities. Rapid initiation of either is key to improving the functional outcome (often emphasized by the common phrase in acute stroke care "time=brain"). Delays between the moment the ambulance is called and the initiation of one or both reperfusion treatment(s) should therefore be as short as possible. The speed of the process strongly depends on five factors: patient location, regional patient allocation by emergency medical services (EMS), travel times of EMS, treatment locations, and in-hospital delays. Regional patient allocation by EMS and treatment locations are sub-optimally configured in daily practice. Our aim is to construct a mathematical model for the joint decision of treatment locations and allocation of acute stroke patients in a region, such that the time until treatment is minimized. We describe acute stroke care as a multi-flow two-level hierarchical facility location problem and the model is formulated as a mixed integer linear program. The objective of the model is the minimization of the total time until treatment in a region and it incorporates volume-dependent in-hospital delays. The resulting model is used to gain insight in the performance of practically oriented patient allocation protocols, used by EMS. We observe that the protocol of directly driving to the nearest stroke centre with special facilities (i.e., the mothership protocol) performs closest to optimal, with an average total time delay that is 3.9% above optimal. Driving to the nearest regional stroke centre (i.e., the drip-and-ship protocol) is on average 8.6% worse than optimal. However, drip-and-ship performs better than the mothership protocol in rural areas and when a small fraction of the population (at most 30%) requires the second procedure, assuming sufficient patient volumes per stroke centre. In the experiments, the time until treatment using the optimal model is reduced by at most 18.9 minutes per treated patient. In economical terms, assuming 150 interventional procedures per year, the value of medical intervention in acute stroke can be improved upon up to € 1,800,000 per year., (© 2021. The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF
49. Complement Evasion by Lyme Disease Spirochetes.
- Author
-
Skare JT and Garcia BL
- Subjects
- Animals, Borrelia burgdorferi genetics, Borrelia burgdorferi physiology, Humans, Immunity, Innate, Ixodes immunology, Ixodes microbiology, Ixodes physiology, Lyme Disease transmission, Borrelia burgdorferi immunology, Complement System Proteins immunology, Immune Evasion, Lyme Disease immunology, Lyme Disease microbiology
- Abstract
The complement system is an ancient arm of the innate immune system that plays important roles in pathogen recognition and elimination. Upon activation by microbes, complement opsonizes bacterial surfaces, recruits professional phagocytes, and causes bacteriolysis. Borreliella species are spirochetal bacteria that are transmitted to vertebrate hosts via infected Ixodes ticks and are the etiologic agents of Lyme disease. Pathogens that traffic in blood and other body fluids, like Borreliella, have evolved means to evade complement. Lyme disease spirochetes interfere with complement by producing a small arsenal of outer-surface lipoproteins that bind host complement components and manipulate their native activities. Here we review the current landscape of complement evasion by Lyme disease spirochetes and provide an update on recent discoveries., (Copyright © 2020 Elsevier Ltd. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
50. Low-Zone IL-2 Signaling: Fusion Proteins Containing Linked CD25 and IL-2 Domains Sustain Tolerogenic Vaccination in vivo and Promote Dominance of FOXP3 + Tregs in vitro .
- Author
-
DeOca KB, Moorman CD, Garcia BL, and Mannie MD
- Subjects
- Animals, Encephalomyelitis, Autoimmune, Experimental genetics, Encephalomyelitis, Autoimmune, Experimental immunology, Encephalomyelitis, Autoimmune, Experimental pathology, Mice, Mice, Transgenic, Recombinant Fusion Proteins pharmacology, Signal Transduction genetics, Signal Transduction immunology, Desensitization, Immunologic, Encephalomyelitis, Autoimmune, Experimental therapy, Immune Tolerance drug effects, Interleukin-2 pharmacology, Interleukin-2 Receptor alpha Subunit, Signal Transduction drug effects, T-Lymphocytes, Regulatory immunology, Vaccination
- Abstract
Low-zone IL-2 signaling is key to understanding how CD4
+ CD25high FOXP3+ regulatory T cells (Tregs) exhibit dominance and overgrow conventional effector T cells (Tcons) that typically express lower levels of the IL-2 receptor alpha chain (i.e., CD25). Thus, modalities such as low-dose IL-2 or IL-2/anti-IL-2 antibody complexes have been advanced in the clinic to selectively expand Treg populations as a treatment for chronic inflammatory autoimmune diseases. However, more effective reagents that efficiently lock IL-2 signaling into a low signaling mode are needed to validate and exploit the low-zone IL-2 signaling niche of Tregs. This study focuses on CD25-IL2 and IL2-CD25 fusion proteins (FPs) that were approximately 32 and 320-fold less potent than IL-2. These FPs exhibited transient binding to transmembrane CD25 on human embryonic kidney (HEK) cells, had partially occluded IL-2 binding sites, and formed higher order multimeric conformers that limited the availability of bioactive IL-2. These FPs exhibited broad bell-shaped concentration ranges that favored dominant Treg outgrowth during continuous culture and were used to derive essentially pure long-term Treg monocultures (∼98% Treg purity). FP-induced Tregs had canonical Treg suppressive activity in that these Tregs suppressed antigen-specific proliferative responses of naïve CD4+ T cells. The in vivo administration of CD25-IL2/Alum elicited robust increases in circulating Tregs and selectively augmented CD25 expression on Tregs but not on Tcons. A single injection of a Myelin Oligodendrocyte Glycoprotein (MOG35-55)-specific tolerogenic vaccine elicited high levels of circulating MOG-specific Tregs in vivo that waned after 2-3 weeks, whereas boosting with CD25-IL2/Alum maintained MOG-specific CD25high Tregs throughout the 30-day observation period. However, these FPs did not antagonize free monomeric IL-2 and lacked therapeutic efficacy in experimental autoimmune encephalomyelitis (EAE). In conclusion, these data reveal that CD25-IL2 FPs can be used to select essentially pure long-term lines of FOXP3+ CD25high Tregs. This study also shows that CD25-IL2 FPs can be administered in vivo in synergy with tolerogenic vaccination to maintain high circulating levels of antigen-specific Tregs. Because tolerogenic vaccination and Treg-based adoptive immunotherapy are limited by gradual waning of Tregs, these FPs have potential utility in sustaining tolerogenic Treg responses in vivo ., (Copyright © 2020 DeOca, Moorman, Garcia and Mannie.)- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.